Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eldecalcitol in postmenopausal osteoporosis and diabetic osteoporosis
ChiCTR2200066283Phase 4Not yet recruiting
- Sponsor
- The Seventh Affiliated Hospital, Sun Yat-Sen University
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of eldecalcitol in osteoporosis (2 arms), sponsored by The Seventh Affiliated Hospital, Sun Yat-Sen University. Primary endpoints: Liver and kidney function, Six electrolytes and 12 more. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
eldecalcitol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ChiCTR2200066283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066283.